Navigation Links
IDIS Opens New American Office in Response to Industry's Growing Need for Pre-Launch Named Patient Programs

LONDON, Aug. 26 /PRNewswire/ -- IDIS, the world leader in the development and implementation of pre-launch Named Patient Programs (NPPs), announces the opening of a new regional office in Iselin, New Jersey, USA. This office places IDIS in a stronger position to support US based pharmaceutical companies in the implementation of programs to support early access of their medicines.

NPPs provide drug developers across the world with a legal and ethical way to make medicines available where appropriate, in response to requests made by physicians, when those medicines are not yet approved in their country or in late-stage clinical trials. The programs that IDIS establishes in partnership with pharmaceutical and biotechnology companies must adhere to the strict regulatory guidelines of the country from which the request originates to allow patients, who have a genuine unmet medical need, with access to potentially life-saving medicines.

The Iselin office will be headed by John Lagus, Vice President of Business & Corporate Development, IDIS, who is leading the expansion of IDIS in the US.

John Lagus said: "This expansion is critical for building our presence in the US for all our global partners, as well as providing proximity to the pharmaceutical and biotechnology companies based in the US. This new office demonstrates IDIS' commitment to our clients, who requested we establish a US presence, and helps the business to further deliver global market access for the pharmaceutical and biotechnology industry through named patient programs, as well as comparator drug sourcing."

In support of companies sponsoring comparative effectiveness clinical trials, IDIS has built expertise in the strategy for and the procurement of comparator drugs. IDIS has a dedicated procurement team that is focused exclusively on identifying reputable sources for comparator drugs from around the world, achieved as a result of extensive and long-running relationships with drug manufacturers.

About IDIS ...

Founded in the UK in 1987, IDIS expanded into Europe six years later, with US pharmaceutical and biotechnology strategic partners established in the last 10 years. IDIS is the world leader in the development and implementation of NPPs.

IDIS is headquartered near central London.

Visit the IDIS website at

Contact: Lynn Blenkhorn of Feinstein Kean Healthcare, +1-508-851-0930

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cartesian Gridspeed Opens Subsidiary Operation in North America
2. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
3. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
4. Kaiser Permanente Colorado Opens Center for Health Dissemination and Implementation Research
5. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
6. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
7. MichBio Expo Opens in Lansing Next Week
8. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
9. NicOx Opens U.S. Headquarters in New Jersey
10. Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice
11. BioEnergy International Facility Opens in Bay State
Post Your Comments:
(Date:11/24/2015)... ... 24, 2015 , ... This fall, global software solutions leader SAP and AdVenture ... develop and pitch their BIG ideas to improve health and wellness in their schools. ... to win the title of SAP's Teen Innovator, an all-expenses paid trip to Super ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... the remaining 11,000 post-share consolidation (or 1,100,000 pre-share ... "Series B Warrants") subject to the previously disclosed ... 23, 2015, which will result in the issuance ... to the issuance of such shares, there will ...
(Date:11/24/2015)... 24, 2015 /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: ... Mr. Pierre Laurin , President and Chief Executive Officer ... upcoming Piper Jaffray 27 th Annual Healthcare Conference to ... 1-2, 2015. st , at 8.50am (ET) ... throughout the day. The presentation will be available live via ...
(Date:11/24/2015)... ... ... Whitehouse Laboratories is pleased to announce that it has completed construction on ... to basic USP 61, USP 62 and USP 51 testing specific to raw materials ... micro testing performed by one supplier. Management has formally announced that the ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
Breaking Biology News(10 mins):